Investor Type

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
Institutional Investor Advisor Individual Investor


Aggressive Growth Strategy

April 2019

Key Takeaways
  • Positive momentum carried equities to new highs, with communication services stocks among the best performers.
  • The potential for M&A activity among exploration and production companies was an encouraging sign that quality assets and free cash flow are being appreciated in the energy sector.
  • Political rhetoric over changes to Medicare and continued scrutiny of drug pricing weighed on the health care sector.
Market Overview

The U.S. equities market notched record highs as the 2019 rally continued in April. The S&P 500 Index rose 4.05%, the Russell 2000 Index advanced 3.40% while the Russell 3000 Index gained 3.99%. Growth stocks once again outperformed their value counterparts, with the benchmark Russell 3000 Growth Index gaining 4.41% compared to 3.56% for the Russell 3000 Value Index.

An accommodative Federal Reserve and signs a trade deal could be reached between the U.S. and China continued to lay a strong foundation for equities, which began the month with their longest winning streak since October 2017. The communication services and information technology (IT) sectors were among the best performers, with diversified media companies and content programmers like Comcast continuing to rebound.

Oil prices rose 6.3% during the month as more positive sentiment on global growth painted a rosier demand picture and the U.S. announced an end to waivers on Iran sanctions, removing some supply already crimped by U.S. sanctions on Venezuela and conflict in Libya.

Energy was a leading contributor to performance as our expectation of increased consolidation in the sector continued to play out with multiple acquisition offers for portfolio holding Anadarko Petroleum. Following an initial $65 per share offer from integrated oil major Chevron, Occidental Petroleum stepped in with a $76 per share bid. While a resolution to the bidding war has not been reached, both companies are drawn to Anadarko’s disciplined approach to production, which is focused on maximizing free cash flow, and its attractive asset base across the shale-rich Permian Basin as well as overseas.

Recent political rhetoric over potentially sweeping changes to Medicare and ongoing scrutiny of prescription drug prices, meanwhile, led to a correction in the health care sector. The portfolio’s overweight to health care was the primary detractor from performance as managed care provider UnitedHealth Group and our largest biotechnology holdings bore the brunt of the selling. We believe, however, that most of the current headwinds facing health care are sentiment-driven and that sound fundamentals and the opportunity for scientific breakthroughs in the clinic remain intact.    



"Current headwinds facing health care are sentiment-driven and sound fundamentals remain intact across the sector."



We have always managed the Aggressive Growth Strategy as long-term business owners, taking small positions in promising companies before they are widely followed or when they are working through short-term issues and holding them as they develop into larger franchises. We believe FireEye, a provider of cybersecurity solutions that help organizations prevent, detect and remediate highly sophisticated cyberattacks, is one such company. We recently initiated a position in FireEye, which is cash flow positive and trades at one of the most attractive valuations in the information security industry.

We continue to see solid results across our technology holdings, which maintain strong competitive positions in the markets they serve. Autodesk, a leader in design software, and TE Connectivity, which develops sensors for applications ranging from electric vehicles and self-driving systems to new 5G wireless technology, were strong performers in April. We believe these types of companies are starting to be recognized as market leadership broadens and the mega cap IT and Internet leaders of the last several years come under greater competitive and regulatory scrutiny.

Portfolio Highlights

The ClearBridge Aggressive Growth Strategy outperformed its Russell 3000 Growth Index benchmark in April. On an absolute basis, the Strategy had gains across six of the eight sectors in which it was  invested (out of 11 sectors total). The primary contributors to performance were the communication services, IT and energy sectors.

Relative to the benchmark, overall stock selection contributed to performance. In particular, stock selection in the energy and communication services sectors and an overweight allocation to  communication services drove relative results. On the negative side, an overweight to the health care sector and stock selection in health care detracted the most from performance.

On an individual stock basis, positions in Anadarko Petroleum, Comcast, TE Connectivity, Autodesk and Twitter were the greatest contributors to absolute returns during the month. The largest detractors included UnitedHealth Group, Vertex Pharmaceuticals, Biogen, Ionis Pharmaceuticals and Amgen.

Evan Bauman

Portfolio Manager
24 Years experience
24 Years at ClearBridge

Richard Freeman

Portfolio Manager
44 Years experience
37 Years at ClearBridge

Related Perspectives

  • Aggressive Growth, Multi Cap Growth Volatility Update
    PM Evan Bauman discusses catalysts that could bring a change in market leadership and how elevated market volatility has created opportunities to reposition the portfolios.
  • Aggressive Growth Strategy
    1Q20 Commentary: We used the spike in volatility to consolidate and reposition the portfolio for the long term.
  • Aggressive Growth Strategy
    4Q19 Commentary: The recent shift in market leadership could be the start of a multi-year trend favoring attractively valued stocks with robust cash flow profiles.
  • Aggressive Growth Strategy
    November 2019 Commentary: Strong relative performance continued as investors recognize companies in less crowded areas of the market.
  • Aggressive Growth Strategy
    October 2019 Commentary: Broadening market participation, highlighted by the rebound of health care, is enabling quality undervalued companies to be monetized.
  • Past performance is no guarantee of future results.

  • All opinions and data included in this commentary are as of the publication date and are subject to change. The opinions and views expressed herein are of the author and may differ from other portfolio managers or the firm as a whole, and are not intended to be a forecast of future events, a guarantee of future results or investment advice. This information should not be used as the sole basis to make any investment decision. The statistics have been obtained from sources believed to be reliable, but the accuracy and completeness of this information cannot be guaranteed. Neither ClearBridge Investments, LLC  nor its information providers are responsible for any damages or losses arising from any use of this information. 

  • Performance source: Internal. Benchmark source: Russell Investments. Frank Russell Company (“Russell”) is the source and owner of the trademarks, service marks and copyrights related to the Russell Indexes. Russell® is a trademark of Frank Russell Company. Neither Russell nor its licensors accept any liability for any errors or omissions in the Russell Indexes and/or Russell ratings or underlying data and no party may rely on any Russell Indexes and/or Russell ratings and/or underlying data contained in this communication. No further distribution of Russell Data is permitted without Russell’s express written consent. Russell does not promote, sponsor or endorse the content of this communication.